LeadIQ logo
Learn more at LeadIQ.com

Insights

Innovative Vaccine Platforms VBI Vaccines' proprietary enveloped virus-like particle technology offers a unique approach to vaccine development, creating opportunities to collaborate with healthcare providers seeking advanced immunization solutions for infectious diseases and cancers.

Expanding Product Portfolio The recent launch of PreHevbri and ongoing development of cancer immunotherapies like VBI-1901 suggest potential sales channels for partners interested in expanding their portfolio of vaccines and immuno-oncology products into new markets.

Strategic Collaborations Partnerships with companies like Brii Biosciences highlight opportunities for joint ventures and licensing deals, particularly in Asian markets, where VBI's vaccines are gaining global rights and market access.

Funding Growth Initiatives Recent financing rounds of up to 30.5 million dollars indicate active investment in R&D and expansion, presenting opportunities for sales in clinical trial support, manufacturing, and regulatory consulting services.

Market Expansion Opportunities VBI's focus on infectious diseases such as hepatitis B and COVID-19, combined with their oncology programs targeting glioblastoma, suggests potential for sales in diagnostics, medical devices, and complementary therapeutics aligned with their pipeline.

VBI Vaccines Inc. Tech Stack

VBI Vaccines Inc. uses 8 technology products and services including WordPress, OneTrust, Modernizr, and more. Explore VBI Vaccines Inc.'s tech stack below.

  • WordPress
    Content Management System
  • OneTrust
    Cookie Compliance
  • Modernizr
    Javascript Libraries
  • Video.js
    Javascript Libraries
  • Erlang
    Programming Languages
  • Google Tag Manager
    Tag Management
  • HTTP/3
    Web & Portal Technology
  • Google Analytics
    Web Analytics

Media & News

VBI Vaccines Inc.'s Email Address Formats

VBI Vaccines Inc. uses at least 1 format(s):
VBI Vaccines Inc. Email FormatsExamplePercentage
FLast@vbivaccines.comJDoe@vbivaccines.com
90%
First.Last@vbivaccines.comJohn.Doe@vbivaccines.com
6%
FirstLast@vbivaccines.comJohnDoe@vbivaccines.com
2%
LastFi@vbivaccines.comDoeJo@vbivaccines.com
2%

Frequently Asked Questions

Where is VBI Vaccines Inc.'s headquarters located?

Minus sign iconPlus sign iconVBI Vaccines Inc.'s main headquarters is located at 160 Second Street Floor 3 Cambridge, Massachusetts 02142 United States. The company has employees across 5 continents, including North AmericaAsiaOceania.

What is VBI Vaccines Inc.'s phone number?

Minus sign iconPlus sign icon You can contact VBI Vaccines Inc.'s main corporate office by phone at
+1-617-830-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is VBI Vaccines Inc.'s official website and social media links?

Minus sign iconPlus sign iconVBI Vaccines Inc.'s official website is vbivaccines.com and has social profiles on LinkedInCrunchbase.

What is VBI Vaccines Inc.'s SIC code NAICS code?

Minus sign iconPlus sign iconVBI Vaccines Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does VBI Vaccines Inc. have currently?

Minus sign iconPlus sign iconAs of February 2026, VBI Vaccines Inc. has approximately 46 employees across 5 continents, including North AmericaAsiaOceania. Key team members include Chief Medical Officer: F. D.Chief Commercial Officer (cco): J. D.Chief Medical Officer: F. D.. Explore VBI Vaccines Inc.'s employee directory with LeadIQ.

What industry does VBI Vaccines Inc. belong to?

Minus sign iconPlus sign iconVBI Vaccines Inc. operates in the Biotechnology Research industry.

What technology does VBI Vaccines Inc. use?

Minus sign iconPlus sign iconVBI Vaccines Inc.'s tech stack includes WordPressOneTrustModernizrVideo.jsErlangGoogle Tag ManagerHTTP/3Google Analytics.

What is VBI Vaccines Inc.'s email format?

Minus sign iconPlus sign iconVBI Vaccines Inc.'s email format typically follows the pattern of FLast@vbivaccines.com. Find more VBI Vaccines Inc. email formats with LeadIQ.

How much funding has VBI Vaccines Inc. raised to date?

Minus sign iconPlus sign icon As of February 2026, VBI Vaccines Inc. has raised $2M in funding. The last funding round occurred on Apr 09, 2024 for $2M.

When was VBI Vaccines Inc. founded?

Minus sign iconPlus sign iconVBI Vaccines Inc. was founded in 2001.

VBI Vaccines Inc.

Biotechnology ResearchMassachusetts, United States11-50 Employees

VBI Vaccines Inc. (“VBI”) is a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease. Through its innovative approach to virus-like particles (“VLPs”), including a proprietary enveloped VLP (“eVLP”) platform technology, VBI develops vaccine candidates that mimic the natural presentation of viruses, designed to elicit the innate power of the human immune system. VBI is committed to targeting and overcoming significant infectious diseases, including hepatitis B, COVID-19 and coronaviruses, and cytomegalovirus (“CMV”), as well as aggressive cancers including glioblastoma (“GBM”). VBI is headquartered in Cambridge, Massachusetts, with research operations in Ottawa, Canada, and a research and manufacturing site in Rehovot, Israel.

To learn more, visit: www.vbivaccines.com

News and Insights: www.vbivaccines.com/news-and-resources/

Investors: www.vbivaccines.com/investors/

Job Opportunities: www.vbivaccines.com/careers/

Section iconCompany Overview

Headquarters
160 Second Street Floor 3 Cambridge, Massachusetts 02142 United States
Phone number
+1-617-830-****
Website
vbivaccines.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2001
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $2M

    VBI Vaccines Inc. has raised a total of $2M of funding over 13 rounds. Their latest funding round was raised on Apr 09, 2024 in the amount of $2M.

  • $1M$10M

    VBI Vaccines Inc.'s revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $2M

    VBI Vaccines Inc. has raised a total of $2M of funding over 13 rounds. Their latest funding round was raised on Apr 09, 2024 in the amount of $2M.

  • $1M$10M

    VBI Vaccines Inc.'s revenue is estimated to be in the range of $1M$10M

Company Leadership

  • Stylized image of a person
    F. D.
    Chief Medical Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. D.
    Chief Commercial Officer (cco)
    Phone icon
    Mobile Phone
  • Stylized image of a person
    F. D.
    Chief Medical Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    O. M.
    Vp Of Quality Global
    Phone icon
    Mobile Phone
  • Stylized image of a person
    N. M.
    President
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    B. O.
    Director, Evlp In Vivo And Toxicology Studies
    Phone icon
    Mobile Phone
  • Stylized image of a person
    V. G.
    Enterprise It Manager
    Phone icon
    Mobile Phone
  • Stylized image of a person
    C. G.
    Key Account Manager
    Phone icon
    Mobile Phone
  • Stylized image of a person
    M. G.
    Senior Scientist
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. C.
    Non Executive Board Member
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.